Weight loss drugs could slash hospital risk for heart failure patients ...Middle East

The weight loss and type 2 diabetes drugs semaglutide and tirzepatide – sold under the brand names Ozempic, Wegovy and Mounjaro – could slash the risk of patients with a type of heart failure ending up in hospital, a study has found.

Hence then, the article about weight loss drugs could slash hospital risk for heart failure patients was published today ( Sunday 31/08/2025 - 10:36 AM ) and is available on The Express & Star ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Weight loss drugs could slash hospital risk for heart failure patients )

Also on site :

• 49 Years Later: The Most Heartbreaking Quotes About the Day Elvis Presley Died, From the Women Who Loved Him
• This Iconic ‘Old Florida’ Attraction Has Been Welcoming Families Since 1949—Here’s What Makes It So Special Today
• INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Futu Holdings Limited (FUTU) Investors of Securities Class Action Lawsuit Deadline on August 25, 2026